[1] 黄元英. 卵巢癌基因治疗的新进展 [J]. 天津药学 2004.doi:10.3969/j.issn.1006-5687.2004.02.027
[2] 苏荣, 李秀萍, 靳更林, 彭丽容, 王丽, 寿成超. 应用噬菌体随机肽库筛选结肠癌患者血清中的肿瘤标记物的研究 [J]. 宁夏医学杂志 2006.doi:10.3969/j.issn.1001-5949.2006.02.002
[3] 江森, 郎景和. 必须重视卵巢恶性肿瘤的诊断、治疗和预防 [J]. 中华妇产科杂志 1992, 27(06).
[4] Whitehouse C, Solomon E. Current stanse of the molecular characterization of the ovarian cancer antigen Cal25 and implocations for its use in clinical screening [J]. Gynecologic Oncology 2003, 88.
[5] Smith GP. Filam entous fusion phage:novel expression vectorsthat display cloned antigens on the virion surfacee [J]. Science 1985, 228(4705).
[6] Ghosh BC. Tumor markers and tumor-associated antigens [M]. New York:Mcgraw-Hill Book Company Inc 1987.
[7] Meyer T, Rustin GJ. [J]. The British journal of cancer 2000.
[8] Masgino T, Gadducci A. Serum markers as prognostic factors in epithelial ovarian cancer:an overview [J]. European Journal of Gynaecological Oncology 2000, 21(01).
[9] Lancaster JM, Sayer R, Blanchette C. Hish expression of tumor necrosis factor related apoptosis-inducing ligand is associated with favorable ovarian cancer survival [J]. Clinical Cancer Research 2003, 9(02).
[10] Sui L, Dong Y, Ohno M, Watanabe Y, Sugimoto K, Tokuda M. Survivin expression and its correlation with cell proliferation and prognosis in epithelial ovarian tumors. [J]. International journal of oncology 2002, 2(2).
[11] Tscng CJ, Jain S, Hou HC. Application of telomerase assay in peritoneal washing fluids [J]. Gynecologic Oncology 2001, 81(03).
[12] Yokoyama Y, Chamock-Jones DS, Licence D. Vascular endothelial growth factor-D is an independent prognostic factor in epithelial ovarian carcinoma [J]. International Journal of Cancer 2003, 88.
[13] Paschke M. Phage display systems and their applications [J]. Applied Microbiology and Biotechnology 2006, 1(1).
[14] Mintz PJ, Kim J, Do KA, Wang X, Zinner RG, Cristofanilli M, Arap MA, Hong WK, Troncoso P, Logothetis CJ, Pasqualini R, Arap W. Fingerprinting the circulating repertoire of antibodies from cancer patients. [J]. Nature biotechnology 2003, 1(1).
[15] Gershoni JM, Roitburd-Berman A, Siman-Tov DD, Tarnovitski-Freund N, Weiss Y. [J]. BioDrugs: Clinical immunotherapeutics, biopharmaceuticals, and gene therapy 2007.
[16] JunjianX, Zhenyu Z, Ning D. Screening of the antigen epitopes of basic fibroblast growth factor by phage display [J]. Journal of Biochemistry and Molecular Biology 2005, 38(03).
[17] Dalgleish A. [J]. IDrugs: the investigational drugs journal 2007.
[18] 曾益新. 肿瘤学 [M]. 北京:人民卫生出版社 2003.
[19] Lauren RH, Krumpe, Toshiyuki Moil. The Use of Phage Displayed Peptide Libraries to Develop Tumor-Targeting Drugs [J]. International Journal of Peptide Research and Therapeutics 2006, 12(01).
[20] Enback J, Laakkonen P. [J]. Biochemical Society Transactions 2007. |
